Hygieia
United States
- Livonia, Michigan
- 02/05/2023
- Series B
- $22,000,000
Hygieia’s d-Nav® Insulin Management System includes an AI-powered application and helps people with Type 2 diabetes use insulin in a safe and effective way. It works by guiding users to adjust their insulin doses – based on changing blood glucose patterns -- every few days rather than three or four times annually. Studies show that some 90 percent of people using our d-Nav® service achieve lower A1c within three months. Patients tell us they feel better; experience fewer complications; spend less time at their physician’s office; and can lower their disease management costs. The d-Nav® insulin management system was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan.
- Industry Medical Equipment Manufacturing
- Website https://d-nav.com/
- LinkedIn https://www.linkedin.com/company/hygieia-inc/
Option Circle | $3,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Chowbus | $81,000,000 | (Mar 12, 2026)
zymtrace | $12,200,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
Xscape Photonics Inc | $37,000,000 | (Mar 12, 2026)
Swarm Aero | $35,000,000 | (Mar 12, 2026)
anchr | $5,800,000 | (Mar 12, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)